NF-κB activation and HIV-1 induced apoptosis

Cytokine and Growth Factor Reviews

Volumn 10, Issue 3-4, 1999, Pages 235-253

  DeLuca, Carmela ^a   Kwon, Hakju ^a   Lin, Rongtuan ^a   Wainberg, Mark ^a   Hiscott, John ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INHIBITOR PROTEIN; PROTEIN KINASE; TUMOR NECROSIS FACTOR ALPHA; CHUK PROTEIN, HUMAN; I KAPPA B; I KAPPA B KINASE; IKBKB PROTEIN, HUMAN; IKBKE PROTEIN, HUMAN; PROTEIN SERINE THREONINE KINASE;

APOPTOSIS; GENE ACTIVATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; NONHUMAN; REVIEW; SIGNAL TRANSDUCTION; VIRUS CELL INTERACTION; VIRUS INFECTION; ACQUIRED IMMUNE DEFICIENCY SYNDROME; AMINO ACID SEQUENCE; ANIMAL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; METABOLISM; MOLECULAR GENETICS; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY;

ACQUIRED IMMUNODEFICIENCY SYNDROME; AMINO ACID SEQUENCE; ANIMALS; APOPTOSIS; HIV INFECTIONS; HIV-1; HUMANS; I-KAPPA B KINASE; I-KAPPA B PROTEINS; MOLECULAR SEQUENCE DATA; NF-KAPPA B; PROTEIN-SERINE-THREONINE KINASES; SIGNAL TRANSDUCTION; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0033233272     PISSN: 13596101     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1359-6101(99)00015-5     Document Type: Review

References (193)

1. Roulston A., Lin R., Beauparlant P., Wainberg M.A., Hiscott J. Regulation of HIV-1 and cytokine gene expression in myeloid cells by NF-κB/Rel transcription factors. Microbiol. Rev. 59:1995;481-505.
2. Verma I.M., Stevenson J.K., Schwarz E.M., Antwerp D.V., Miyamoto S. Rel/NF-κB/IκB family: intimate tales of association and dissociation. Genes Dev. 9:1995;2723-2735.
3. Baldwin A.S. Jr. The NF-κB and IκB proteins: new discoveries and insights. Annu. Rev. Immunol. 14:1996;649-681.
4. Lin L., DeMartino G.N., Greene W.C. Cotranslational biogenesis of NF-κB p50 by the 26 S proteasome. Cell. 92:1998;819-828.
5. Lin R., Gewert D., Hiscott J. Differential transcriptional activation in vitro by NF-κB/Rel proteins. J. Biol. Chem. 270:1995;3123-3131.
6. Baeuerle P.A., Henkel T. Function and activation of NF-κB in the immune system. Annu. Rev. Immunol. 12:1994;141-179.
7. Siebenlist U., Franzoso G., Brown K. Structure, regulation and function of NF-κB. Annu. Rev. Cell. Biol. 10:1995;405-455.
8. Sha W.C., Liou H.-C., Tuomanen E.I., Baltimore D. Targeted disruption of the p50 subunit of NF-κB leads to multifocal defects in immune responses. Cell. 80:1995;321-330.
9. Weih F., Carrasco D., Durham S.K., Barton D.S., Rizzo C.A., Ryseck R.-P., Lira S.A., Bravo R. Multiorgan inflammation and hematopoietic abnormalities in mice with a targeted disruption of RelB, a member of the NF-κB/Rel family. Cell. 80:1995;331-340.
10. Burkly L., Hession C., Ogata L., Reilly C., Marconi L.A., Olson D., Tizard R., Cate R., Lo D. Expression of RelB is required for the development of thymic medulla and dendritic cells. Nature. 373:1995;531-536.
11. Beg A.A., Sha W.C., Bronson R.T., Ghosh S., Baltimore D. Embryonic lethality and liver degeneration in mice lacking the RelA component of NF-κB. Nature. 376:1995;167-170.
12. Wang C.Y., Mayo M.W., Baldwin A.S. TNF- and cancer therapy-induced apoptosis: potentiation by inhibition of NF-κB. Science. 274:1996;784-787.
13. Van Antwerp D.J., Martin S.J., Kafri T., Green D.R., Verma I.M. Suppression of TNF-α-induced apoptosis by NF-κB. Science. 274:1996;787-789.
14. Beg A.A., Baltimore D. An essential role for NF-κB in preventing TNF-α-induced cell death. Science. 274:1996;782-784.
15. Beg A.A., Baldwin S. Jr. The IκB proteins: multifunctional regulators of Rel/NF-κB transcription factors. Genes Dev. 7:1993;2064-2070.
16. Palombella V.J., Rando O.J., Goldberg A.L., Maniatis T. The ubiquitin-proteosome pathway is required for processing the NF-κB1 precursor protein and the activation of NF-κB. Cell. 78:1994;773-785.
17. Baeuerle P.A. IκB-NF-κB structures: at the interface of inflammation Control. Cell. 95:1998;729-731.
18. Jacobs M.D., Harrison S.C. Structure of an IκBα/NF-κB complex. Cell. 95:1998;749-758.
19. Huxford T., Huang D.-B., Malek S., Ghosh G. The crystal structure of the IκBα/NF-κB complex reveals mechanisms of NF-κB inactivation. Cell. 95:1998;759-770.
20. Dechend R., Hirano F., Lehmann K., Heissmeyer V., Ansieau S., Wulczyn G.G., Scheidereit C., Leutz A. The Bcl-3 oncoprotein acts as a bridging factor between NF-κB/Rel and nuclear co-regulators. Oncogene. 18:1999;3316-3323.
21. Baeuerle P.A., Baltimore D. IκB: a specific inhibitor of the NF-κB transcription factor. Science. 242:1988;540-546.
22. Barroga C.F., Stevenson J.K., Schwarz E.M., Verma I.M. Constitutive phosphorylation of IκBα by casein kinase II. Proc. Natl. Acad. Sci. USA. 92:1995;7637-7641.
23. Lin R., Beauparlant P., Makris C., Meloche S., Hiscott J. Phosphorylation of IκBα in the C-terminal PEST domain by casein kinase II affects intrinsic protein stability. Mol. Cell. Biol. 16:1996;1401-1409.
24. Schwarz E., Antwerp D., Verma I. Constitutive phosphorylation of IκBα by casein kinase II occurs preferentially at serine 293: requirement for degradation of free IκBα Mol. Cell. Biol. 16:1996;3554-3559.
25. Ossareh-Nazari B., Bachelerie F., Dargemont C. Evidence for a role of CRM1 in signal-mediated nuclear protein export. Science. 278:1997;141-144.
26. Chen Z.J., Parent L., Maniatis T. Site-specific phosphorylation of IκBα by a novel ubiquitination-dependent protein kinase activity. Cell. 84:1996;853-862.
27. Régnier C., Song H.Y., Gao X., Goeddel D.V., Cao Z., Rothe M. Identification and characterization of an IκB kinase. Cell. 90:1997;373-383.
28. DiDonato J.A., Hayakawa M., Rothwarf D.M., Zandi E., Karin M. A cytokine-responsive IκB kinase that activates the transcription factor NF-κB. Nature. 388:1997;548-554.
29. Mercurio F., Zhu H., Murray B.W., Shevchenko A., Bennett B.L., Li J.W., Young D.B., Barbosa M., Mann M. IKK-1 and IKK-2: cytokine-activated IκB kinases essential for NF-κB activation. Science. 278:1997;860-866.
30. Zandi E., Rothwarf D.M., Delhase M., Hayakawa M., Karin M. The IκB kinase complex (IKK) contains two kinase subunits, IKKα and IKKβ, necessary for IκB phosphorylation and NF-κB activation. Cell. 91:1997;243-252.
31. Woronicz J.D., Gao X., Cao Z., Rothe M., Goeddel D.V. IκB kinase-β: NF-κB activation and complex formation with IκB kinase-α and NIK. Science. 278:1997;866-869.
32. Traenckner E.B.-M., Wilk S., Baeuerle P.A. A proteasome inhibitor prevents activation of NF-κB and stabilizes a newly phosphorylated form of IκB-α that is still bound to NF-κB. EMBO J. 13:1994;5433-5441.
33. Chen Z., Hagler J., Palombella V.J., Melandri F., Scherer D., Ballard D., Maniatis T. Signal-induced site-specific phosphorylation targets IκBα to the ubiquitin-proteasome pathway. Genes Dev. 9:1995;1586-1597.
34. Traenckner E.B.M., Pahl H.L., Henkel T., Schmidt K.N., Wilk S., Baeuerle P.A. Phosphorylation of human IκBα on serines 32 and 36 controls IκBα proteolysis and NF-κB activation in response to diverse stimuli. EMBO J. 14:1995;2876-2883.
35. Scherer D.C., Brockman J.A., Chen Z., Maniatis T., Ballard D.W. Signal-induced degradation of IκBα requires site-specific ubiquitination. Proc. Natl. Acad. Sci. USA. 92:1995;11,259-11,263.
36. Baldi L., Brown K., Franzoso G., Siebenlist U. Critical role for lysines 21 and 22 in signal-induced, ubiquitin-mediated proteolysis of IκBα J. Biol. Chem. 271:1996;376-379.
37. Li C.-C.H., Dai R.-M., Longo D.L. Inactivation of NF-κB inhibitor IκBα: ubiquitin-dependent proteolysis and its degradation product. Biochem. Biophys. Res. Comm. 215:1995;292-301.
38. Yaron A., Hatzubai A., Davis M., Lavon I., Amit S., Manning A.M., Andersen J.S., Mann M., Mercurio F., Ben-Neriah Y. Identification of the receptor component of the IκBα-ubiquitin ligase. Nature. 396:1998;590-594.
39. Beauparlant P., Kwon H., Clarke M., Lin R., Sonenberg N., Wainberg M., Hiscott J. Transdominant mutants of IκBα block Tat-TNF synergistic activation of HIV-1 expression and virus multiplication. J. Virol. 70:1996;5777-5785.
40. Kwon H., Pelletier N., DeLuca C., Genin P., Cisternas S., Lin R., Wainberg M.A., Hiscott J. Inducible expression of IκBα repressor mutants interferes with NF-κB activity and HIV-1 replication in Jurkat T cells. J. Biol. Chem. 273:1998;7431-7440.
41. Beauparlant P., Lin R., Hiscott J. The role of the C-terminal domain of IκBα in protein degradation and stability. J. Biol. Chem. 271:1996;10,690-10,696.
42. Whiteside S.T., Israel S. IκB proteins: structure, function and regulation. Cancer Biology. 8:1997;75-82.
43. Sun S.-C., Elwood J., Greene W.C. Both amino- and carboxyl-terminal sequences within IκBα regulate its inducible degradation. Mol. Cell. Biol. 16:1996;1058-1065.
44. Van Antwerp D.J., Verma I. Signal-induced degradation of IκBα: association with NF-κB and the PEST sequence in IκBα are not required. Mol. Cell. Biol. 16:1996;6037-6045.
45. Aoki T., Sano Y., Yamamoto T., Inoue J. The ankyrin repeats but not the PEST-like sequences are required for signal-dependent degradation of IκBα Oncogene. 12:1996;1159-1164.
46. Tran K., Merika M., Thanos D. Distinct functional properties of IκBα and IκBβ Mol. Cell. Biol. 17:1997;5386-5399.
47. Chu Z.-L., McKinsey T.A., Liu L., Qi X., Ballard D. Basal phosphorylation of the PEST domain in IkBβ regulates its functional interaction with the c-rel proto-oncogene product. Mol. Cell. Biol. 16:1996;5974-5984.
48. McKinsey T.A., Chu Z.L., Ballard D.W. Phosphorylation of the PEST domain of IκBβ regulates the function of NF-κB/IκBβ complexes. J. Biol. Chem. 272:1997;22,377-22,380.
49. Thompson J.E., Phillips R.J., Erdjument-Bromage H., Tempst P., Ghosh S. IκB-β regulates the persistent response in a biphasic activation of NF-κB. Cell. 80:1995;573-582.
50. Weil R., Laurent-Winter C., Israel A. Regulation of IκBβ degradation: similarities to and differences from IκBα J. Biol. Chem. 272:1997;9942-9949.
51. Harhaj E.W., Sun S.C. The serine/threonine phosphatase inhibitor calyculin A induces rapid degradation of IκBβ: requirements of both the N- and C-terminal sequences. J. Biol. Chem. 272:1997;5409-5412.
52. Suyang H., Phillips R., Douglas I., Ghosh S. Role of unphosphorylated, newly synthesized IκBβ in persistent activation of NF-κB. Mol. Cell. Biol. 16:1996;5444-5449.
53. Phillips R.J., Ghosh S. Regulation of IκBβ in WEHI 231 mature B cells. Mol. Cell. Biol. 17:1997;4390-4396.
54. Attar R.M., MacDonald-Bravo H., Raventos-Suarez C., Durham S.K., Bravo R. Expression of constitutively active IκBβ in T cells of transgenic mice: peristent NF-κB activity is required for T-cell immune responses. Mol. Cell. Biol. 18:1998;477-487.
55. Whiteside S.T., Epinat J.C., Rice N.R., Israel A. I kappa B epilson, a novel member of the IκB family, controls RelA and c-Rel NF-κB activity. EMBO J. 16:1997;1413-1426.
56. Menon S.D., Qin S., Guy G.R., Tan Y.H. Differential induction of nuclear NF-κB by protein phosphatase inhibitors in primary and transformed human cells. J. Biol. Chem. 268:1993;26,805-26,812.
57. Sun S.-C., Maggirwar S.B., Harhaj E. Activation of NF-κB by phosphatase inhibitors involves the phosphorylation of IκBα at phosphatase 2A-sensitive sites. J. Biol. Chem. 270:1995;18,347-18,351.
58. Singh S., Aggarwal B.B. Protein-tyrosine phosphatase inhibitors block tumor necrosis factor-dependent activation of the nuclear transcription factor NF-κB. J. Biol. Chem. 270:1995;10,631-10,639.
59. Menon S.D., Guy G.R., Tan Y.H. Involvement of a putative protein-tyrosine phosphatase and IκB-α serine phosphorylation in nuclear factor κB activation by tumor necrosis factor. J. Biol. Chem. 270:1995;18,881-18,887.
60. Maniatis T. Catalysis by a multiprotein IκB kinase complex. Science. 278:1997;818-819.
61. Stancovski I., Baltimore D. NF-κB activation: the IκB kinase revealed? Cell. 91:1997;299-302.
62. Rothwarf D.M., Zandi E., Natoli G., Karin M. IKK-γ is an essential regulatory subunit of the IκB kinase complex. Nature. 395:1998;297-300.
63. Yamaoka S., Courtois G., Bessia C., Whiteside S.T., Weil R., Agou F., Kirk H.E., Kay R.J., Israel A. Complementation cloning of NEMO, a component of the IκB kinase complex essential for NF-κB activation. Cell. 93:1998;1231-1240.
64. Cohen L., Henzel W.J., Baeuerle P.A. IKAP is a scaffold protein of the IκB kinase complex. Nature. 395:1998;292-296.
65. Ling L., Cao Z., Goeddel D.V. NF-κB-inducing kinase activates IKK-α by phosphorylation of Ser-176. Proc. Natl. Acad. Sci. USA. 95:1998;3792-3797.
66. Ninomiya-Tsuji J., Kishimoto K., Hiyama A., Inoue J., Cao Z., Matsumoto K. The kinase TAK1 can activate the NIK-IκB as well as the MAP kinase cascade in the IL-1 signaling pathway. Nature. 398:1999;252-256.
67. Lin X., Cunningham E.T. Jr, Mu Y., Geleziunas R., Greene W.C. The proto-oncogene Cot kinase participates in CD3/CD28 induction of NF-κB acting through the NIK and IκB kinases. Immunity. 10:1999;271-280.
68. Lee F.S., Hagler J., Chen Z.J., Maniatis T. Activation of the IκBα kinase complex by MEKK1, a kinase of the JNK pathway. Cell. 88:1997;213-222.
69. Baud V., Liu Z.G., Bennett B., Suzuki N., Xia Y., Karin M. Signaling by proinflammatory cytokines: oligomerization of TRAF2 and TRAF6 is sufficient for JNK and IKK activation and target gene induction via an amino terminal effector domain. Genes Dev. 13:1999;1297-1308.
70. Zandi E., Karin M. Bridging the gap: composition, regulation and physiological function of the IκB kinase complex. Mol. Cell. Biol. 19:1999;4547-4551.
71. Delhase M., Hayakawa M., Chen Y., Karin M. Positive and negative regulation of the IκB kinase activity through IKKβ subunit phosphorylation. Science. 284:1999;309-313.
72. Li Q., Van Antwerp D., Mercurio F., Lee K.F., Verma I.M. Severe liver degeneration in mice lacking the IKK2 gene. Science. 284:1999;321-325.
73. Tanaka M., Fuentes M.E., Yamaguchi K., Durin M.H., Dalrymple S.A., Hardy K.L., Goeddel D.V. Embrionic lethality, liver degeneration, and impaired NF-κB activation in IKKβ deficient mice. Immunity. 10:1999;421-429.
74. Li Z.W., Chu W., Hu Y., Delhase M., Deerinck T., Ellisman M., Johnson R., Karin M. The IKKβ subunit of IKK is essential for NF-κB activation and prevention of apoptosis. J. Exp. Med. 189:1999;1839-1845.
75. Li Q., Lu Q., Hwang J.Y., Buscher D., Lee K.F., Izpisua-Belmonte J.C., Verma I.M. IKK1-deficient mice exhibit abnomal development of skin and skeleton. Genes Dev. 13:1999;1322-1328.
76. Bours V., Burd P.R., Brown K., Villalobos J., Park S., Ryseck R.-P., Bravo R., Kelly K., Siebenlist U. A novel mitogen-inducible gene product related to p50/p105-NF-κB participates in transactivation through a κB site. Mol. Cell. Biol. 12:1992;685-695.
77. Finco T.S., Baldwin A.S. Jr. κB site-dependent induction of gene expression by diverse inducers of nuclear factor κB requires Raf-1. J. Biol. Chem. 268:1993;17,676-17,679.
78. Spencer W., Kwon H., Crepieux P., Leclerc N., Lin R., Hiscott J. Taxol selectively blocks microtubule dependent NF-κB activation by phorbal ester via inhibition of IκBα phosphorylation and degradation. Oncogene. 18:1999;495-505.
79. Lallena M.-J., Diaz-Meco M.T., Bren G., Payá C.V., Moscat J. Activation of IκB kinase by protein kinase C isoforms. Mol. Cell. Biol. 19:1999;2180-2188.
80. Muller G., Ayoub M., Storz P., Rennecke J., Fabbro D., Pfizenmaier K. PKCζ is a molecular switch in signal transduction of TNF-α, bifunctionally regulated by ceramide and arachidonic acid. EMBO J. 14:1999;1961-1969.
81. Schouten G.J., Vertegaal A.C., Whiteside S.T., Israel A., Toebes M., Dorsman J.C., van der Eb A.J., Zantema A. IκBα is a target for the mitogen-activated 90 kDa ribosomal S6 kinase. EMBO J. 16:1997;3133-3144.
82. Kumar A., Haque J., Lacoste J., Hiscott J., Williams B.R.G. Double-stranded RNA-dependent protein kinase activates transcription factor NF-κB by phosphorylating IκB. Proc. Natl. Acad. Sci. USA. 91:1994;6288-6292.
83. Kumar A., Yang Y.-L., Flati V., Der S., Kadereit S., Deb A., Haque J., Reis L., Weissman C., Williams B.R.G. Deficient cytokine signalling in mouse embryo fibroblasts with a targeted deletion in the PKR gene: role of IRF-1 and NF-κB. EMBO J. 16:1997;406-416.
84. Baker S.J., Reddy E.P. Transducers of life and death: TNF receptor superfamily and associated proteins. Oncogene. 12:1996;1-9.
85. Darnay B.G., Aggarwal B.B. Early events in TNF signaling: a story of associations and dissociations. J. Leukoc. Biol. 61:1997;559-566.
86. Hsu H., Xiong J., Goeddel D.V. The TNF receptor 1-associated protein TRADD signals cell death and NF-κB activation. Cell. 81:1995;495-504.
87. Song H.Y., Regnier C.H., Kirschning C.J., Goeddel D.V., Rothe M. Tumor necrosis factor (TNF)-mediated kinase cascades: bifurcation of nuclear factor-κB and c-jun N-terminal kinase (JNK/SAPK) pathways at TNF receptor-associated factor 2. Proc. Natl. Acad. Sci. USA. 94:1997;9792-9796.
88. Yeh W.C., Shahinian A., Speiser D., Kraunus J., Billia F., Wakeham A., Pompa J.L., Ferrick D., Hum B., Iscove N., Ohashi P., Rothe M., Goeddel D.V., Mak T.W. Early lethality, functional NF-κB activation, and increased sensitivity to TNF-induced cell death in TRAF2-deficient mice. Immunity. 7:1997;715-725.
89. Stanger B.Z., Leder P., Lee T.-H., Kim E., Seed B. RIP: a novel protein containing a death domain that interacts with Fas/APO-1 (CD95) in yeast and causes cell death. Cell. 81:1995;513-523.
90. Hsu H., Huang J., Shu S.H., Baichwal V., Goeddel D.V. TNF-dependent recruitment of the protein kinase RIP to the TNF receptor-1 signalling complex. Immunity. 4:1997;387-396.
91. Sanz L., Sanchez P., Lallena M.-J., Diaz-Meco M.T., Moscot J. The interaction of p62 with RIP links the atypical PKCs to NF-κB activation. EMBO J. 18:1999;3044-3053.
92. Lacoste J., Cohen L., Hiscott J. NF-κB activity in T cells stably expressing the Tax protein of HTLV-1. Virol. 184:1991;553-562.
93. Arima N., Molitor J.A., Smith M.R., Kim J.H., Daitoku Y., Greene W.C. Human T-cell leukemia virus type I Tax induces expression of the rel-related family of κB enhancer-binding proteins: evidence for a pretranslational component of regulation. J. Virol. 65:1991;6892-6899.
94. Kanno T., Brown K., Siebenlist U. Evidence in support of a role for human T-cell leukemia virus type I Tax in activating NF-κB via stimulation of signaling pathways. J. Biol. Chem. 270:1995;11,745-11,748.
95. Scala G., Ruocco M., Ambrosino C., Mallardo M., Giordano V., Baldassare F., Dragonetti E., Quinto I., Venuta S. Expression of the IL-6 gene is induced by HIV-1 tat protein. Proc. Natl. Acad. Sci. USA. 179:1994;961-971.
96. Herrero J.A., Mathew P., Paya C.V. LMP-1 activates NF-κB by targeting the inhibitory molecule IκBα J. Virol. 69:1995;2168-2174.
97. Farrell P.J. Signal transduction from the Epstein-Barr virus LMP-1 transforming protein. Trends in Microbiology. 6:1998;175-177.
98. Yin M.-J., Christerson L.B., Yamamoto Y., Kwak Y.-T., Xu S., Mercurio F., Barbosa M., Cobb M.H., Gaynor R.B. HTLV-I Tax protein binds to MEKK1 to stimulate IκB kinase activity and NF-κB activation. Cell. 93:1998;875-884.
99. Chu Z.-L., Didonato J., Hawiger J., Ballard D.W. The Tax oncoprotein of human T-cell leukemia virus type 1 associates with and persistently activates IκB kinases containing IKKα and IKKβ J. Biol. Chem. 273:1998;15,891-15,894.
100. Uhlik M., Good L., Xiao G., Harhaj E., Zandi E., Karin M., Sun S.-C. NF-κB-inducing kinase and IκB kinase participate in human T-cell leukemia virus 1 Tax-mediated NF-κB activation. J. Biol. Chem. 273:1998;21,132-21,136.
101. Chu Z.L., Shin Y.A., Yang J.M., DiDonato J.A., Ballard D.W. IKKγ mediates the interaction of cellular IκB kinases with the Tax transforming protein of HTLV-1. J. Biol. Chem. 274:1999;15,297-15,300.
102. Jin D.Y., Giordano V., Kibler K.V., Nakano H., Jeang K.T. Role of adaptor function in oncoprotein-mediated activation of NF-κB. HTLV-1 Tax interacts directly with IKKγ J. Biol. Chem. 274:1999;17,402-17,405.
103. Suzuki T., Hirai H., Yoshida M. Tax protein of HTLV-I interacts with the Rel homology domain of NF-κB binding p65 and c-Rel proteins bound to the NF-κB binding site and activates transcription. Oncogene. 9:1994;3099-3105.
104. Petropoulos L., Lin R., Hiscott J. Human T cell leukemia virus type 1 Tax protein increases NF-κB dimer formation and antagonizes the inhibitory activity of the IκBα regulatory protein. Virol. 225:1996;52-64.
105. Petropoulos L., Hiscott J. Association between HTLV-1 Tax and IκBα is dependent on the IκBα phosphorylation state. Virol. 252:1998;189-199.
106. Hiscott J., Petropoulos L., Lacoste J. Molecular interactions between HTLV-1 Tax protein and the NF-κB/IκB transcription complex. Virol. 214:1995;3-11.
107. Demarchi F., Gutierrez M.I., Giacca M. HIV-1 Tat protein activates transcription factor NF-κB through the cellular interferon-inducible, double stranded RNA-dependent protein kinase PKR. J. Virol. 73:1999;7080-7086.
108. DeLuca C., Roulston A., Koromilas A., Wainberg M.A., Hiscott J. Chronic human immunodeficiency virus type I infection of myeloid cells disrupts the autoregulatory control of the NF-κB/Rel pathway via enhanced IκBα degradation. J. Virol. 70:1996;5183-5193.
109. DeLuca C., Petropoulos L., Zmeureanu D., Hiscott J. Nuclear IκBβ maintains persistent NF-κB activation in HIV-1-infected myeloid cells. J. Biol. Chem. 274:1999;13,010-13,016.
110. Asin S., Taylor J.A., Trushin S., Bren G., Paya C.V. IKK mediates NF-κB activation in HIV-infected cells. J. Virol. 73:1999;3893-3903.
111. Westendorp M.O., Shatrov V.A., Schulze-Osthoff K., Frank R., Kraft M., Los M., Krammer P.H., Drige W., Lehnann V. HIV-1 Tat potentiates TNF-induced NF-κB activation and cytotoxicity by altering the cellular redox state. EMBO J. 14:(3):1995;546-554.
112. Albini A., Ferrini S., Benelli R., Sforzini S., Giunciuglio D., Aluigi M.G., Proudfoot A.E.I., Alouani S., Wells T.N.C., Mariani G., Rabin R.L., Farber J.M., Noonan D.M. HIV-1 tat protein mimicry of chemokines. Proc. Natl. Acad. Sci. USA. 95:1998;13,153-13,158.
113. Quinto I., Mallardo M., Baldassarre F., Scala G., Englund G., Jeang K.T. Potent and stable attenuation of live HIV-1 by gain of a proteolysis-resistant inhibitor of NF-κB (IκBα S32/36A) and the implications for vaccine development. J. Biol. Chem. 274:1999;17,567-17,572.
114. Briant L., Robert-Hebmann V., Acquaviva C., Pelchen-Matthews A., Marsh M., Devaux C. The protein tyrosine kinase p56lck is required for triggering NF-κB activation upon interaction of human immunodeficiency virus type 1 envelope glycoprotein gp120 with cell surface CD4. J. Virol. 72:1998;6207-6214.
115. Nolan G.P., Baltimore D. The inhibitory ankyrin and activator Rel proteins. Curr. Opin. Gen. Dev. 2:1992;211-220.
116. Yang Y.-L., Reis L.F.L., Pavlovic J., Aguzzi A., Schaefer R., Kumar A., Williams B.R.G., Aguet M., Weissman C. Deficient signalling in mice devoid of double-stranded RNA-dependent protein kinase. EMBO J. 14:1995;6095-6106.
117. Proud C.G. PKR: a new name and new roles. TIBS. 20:1995;241-246.
118. Clemens M.J., Elia A. The double-stranded RNA-dependent protein kinase PKR: structure and function. J. Interferon Cytokine Res. 17:1997;503-524.
119. Meurs E.F., McMillan N., Williams B.R.G., Hovanessian A.G., Southern P.J. Human PKR transfected into murine cells stimulates expression of genes under control of the HIV1 or HTLV-1 LTR. Virol. 214:1995;653-659.
120. Koromilas A.E., Roy S., Barber G.N., Katze M.G., Sonenberg N. Malignant transformation by a mutant of the IFN-inducible dsRNA-dependent protein kinase. Science. 257:1992;1685-1689.
121. Yeung M.C., Lau A.S. Tumor suppressor p53 as a component of the TNF induced, PKR mediated apoptotic pathway in human promonocytic U937 cells. J. Biol. Chem. 273:1998;25,198-25,202.
122. Wu H., Lozano G. NF-kappa B activation of p53: a potential mechanism for suppressing cell growth in response to stress. J. Biol. Chem. 269:1994;20,067-20,074.
123. Gil J., Alcami J., Esteban M. Induction of apoptosis by dsRNA-dependent protein kinase (PKR) involves the alpha subunit of eukaryotic translation initiation factor 2 and NF-κB. Mol. Cell. Biol. 19:1999;4653-4663.
124. Tang N.M., Korth M.J., Gale M. Jr, Wambach M., Der S.D., Bandyopadhyay S.K., Williams B.R., Katze M.G. Inhibition of dsRNA- and TNFα-mediated apoptosis by tetratricopeptide repeat protein and cochaperone P58(IPK). Mol. Cell. Biol. 19:1999;4757-4765.
125. Balachandran S., Kim C.N., Yeh W.C., Mak T.W., Bhalla K., Barber G.N. Activation of the dsRNA-dependent protein kinase, PKR, induces apoptosis through FADD-mediated death signaling. EMBO J. 17:1998;6888-6902.
126. Ray C.A., Black R.A., Kronheim S.R., Greenstreet T.A., Sleath P.R., Salvesen G.S., Pickup D.J. Viral inhibition of inflammation: cowpox virus encodes an inhibitor of the interleukin-1β converting enzyme. Cell. 69:1992;597-604.
127. Vaux D.L., Haecker G., Strasser A. An evolutionary perspective on apoptosis. Cell. 76:1994;777-779.
128. Chu C.H., McKinsey T., Liu L., Gentry J., Malim M., Ballard D.W. Suppression of tumor necrosis factor-induced cell death by inhibitor of apoptosis c-IAP2 is under NF-κB control. Proc. Natl. Acad. Sci. USA. 94:1997;10,057-10,062.
129. Wang C.Y., Mayo M.W., Korneluk R.G., Goeddel D.V., Baldwin A.S. Jr. NF-κB antiapoptosis: induction of TRAF1 and TRAF2 and c-IAP1 and c-IAP2 to suppress caspase-8 activation. Science. 281:1998;1680-1683.
130. Martz E., Howell D.M. CTL: virus control cells first and cytolytic cells second? DNA fragmentation, apoptosis and the prelytic halt hypothesis. Immunol. Today. 10:1989;79-86.
131. Froelich C.J., Dixit V.M., Yang X. Lymphocyte granule-mediated apoptosis: matters of viral mimicry and deadly proteases. J. Immunol. 19:1998;30-36.
132. Talanian R.V., Yang X., Turbov J., Seth P., Ghayur T., Casiano C.A., Orth K., Froelich C.J. Granule-mediated killing: pathways for granzyme B-initiated apoptosis. J. Exp. Med. 186:1997;1323-1331.
133. Tanaka N., Sato M., Lamphier M.S., Nozawa H., Oda E., Noguchi S., Schreiber R.D., Tsujimoto Y., Taniguchi T. Type I interferons are essential mediators of apoptotic death in virally infected cells. Genes to Cells. 3:1998;29-37.
134. Gougeon M.L., Montagnier L. Apoptosis in AIDS. Science. 260:1993;1269-1270.
135. Laurent-Crawford A.G., Bernard K., Muller S., Riviere Y., Rey-Cuille M.A., Bechet J.M., Montagnier L., Hovanessian A.G. The cytopathic effect of HIV is associated with apoptosis. Virol. 185:1991;829-839.
136. Maldarelli F., Sato H., Berthold E., Orenstein J., Martin M.A. Rapid induction of apoptosis by cell-to-cell transmission of human immunodeficiency virus type 1. J. Virol. 69:(10):1995;6457-6465.
137. Bartz S.A., Emerman M. HIV-1 tat induces apoptosis and increases sensitivity to apoptotic signals by up-regulating FLICE/Caspase-8. J. Virol. 73:1999;1956-1963.
138. Casella C.R., Rapaport E.L., Finkel T.H. Vpu increases susceptibility of HIV-1 infected cells to Fas killing. J. Virol. 73:1999;92-100.
139. Kerr J.F., Wyllie A.H., Currie A.R. Apoptosis: a basic biological phenomenon with wide ranging implications in tissue kinetics. Brit. J. Cancer. 26:1972;239-257.
140. Orth K., Chinnaiyan A.M., Garg M., Froelich C.J., Dixit V.M. The CED-3/ICE-like protease Mch2 is activated during apoptosis and cleaves the death substrate lamin A. J. Biol. Chem. 271:1996;16,443-16,446.
141. Hengartner M.O., Horvitz H.R. Programmed cell death in Caenorhabditis elegans. Curr. Opin. Gen. Dev. 4:1994;581-586.
142. Ellis H.M., Horvitz H.R. Genetic control of programmed cell death in the nematode C. elegans. Cell. 44:1986;817-829.
143. Hengartner M.O., Ellis R.E., Horvitz H.R. Caenorhabditis elegans gene ced-9 protects cells from programmed cell death. Nature. 356:1992;494-499.
144. Minn A.J., Swain R.E., Ma A., Thompson C.B. Recent progress on the regulation of apoptosis by Bcl-2 family members. Adv. Immunol. 70:1998;245-279.
145. Chinnaiyan A.M., Chaudhary D., O'Rourke K., Koonin E.V., Dixit V.M. Role of CED-4 in the activation of CED-3. Nature. 388:1997;728-729.
146. Wu D., Wallen H.D., Nunez G. Interaction and regulation of subcellular localization of CED-4 by CED-9. Science. 275:1997;1126-1129.
147. Seshagiri S., Miller L.K. Caenorhabditis elegans CED-4 stimulates CED-3 processing and CED-3-induced apoptosis. Current Biology. 7:1997;455-460.
148. Raff M.C. Social controls on cell survival and cell death. Nature. 356:1992;397-400.
149. Ashkenazi A., Dixit V.M. Death receptors: signaling and modulation. Science. 281:1998;1305-1308.
150. Adams J.M., Cory S. The Bcl-2 protein family: arbiters of cell survival. Science. 281:1998;1322-1326.
151. Susin S.A., Zamzami N., Castedo M., Hirsch T., Marchetti P., Macho A., Daugas E., Geuskens M., Kroemer G. Bcl-2 inhibits the mitochondrial release of an apoptogenic protease. J. Exp. Med. 184:1996;1331-1334.
152. Baichwal V.R., Baeuerle P.A. Apoptosis: activate NF-κB or die? Current Biology. 7:1997;R94-R96.
153. Wu M., Lee H., Bellas R.E., Schauer S.L., Arsura M., Katz D., FitzGerald M.J., Rothstein T.L., Sherr D.H., Sonenshein G.E. Inhibition of NF-κB/Rel induces apoptosis of murine B cells. EMBO J. 15:1996;4682-4690.
154. Grumont R.J., Rourke I.J., Gerondakis S. Rel-dependent induction of A1 transcription is required to protect B cells from antigen receptor ligation-induced apoptosis. Genes Dev. 13:1999;400-411.
155. DeLuca C., Kwon H.J., Pelletier N., Wainberg M.A., Hiscott J. NF-κB protects HIV-1 infected myeloid cells from apoptosis. Virol. 244:1998;27-38.
156. Jaattela M., Mouritzen H., Elling F., Bastholm L. A20 zinc finger protein inhibits TNF and IL-1 signalling. J. Immunol. 156:1996;1166-1173.
157. Tewari M., Dixit V.M. Recent advances in tumor necrosis factor and CD40 signaling. Curr. Opin. Gen. Dev. 6:1996;39-44.
158. Yang E., Korsmeyer S.J. Molecular thanatopsis: a discourse on the Bcl-2 family and cell death. Blood. 88:1996;386-401.
159. Reed J.C., Miyashita T., Takayama S., Wang H.G., Sato T., Krajewski S., Aime-Sempe C., Bodrug S., Kitada S., Hanada M. Bcl-2 family proteins: regulators of cell death involved in the pathogenesis of cancer and resistance to therapy. J. Cell. Biochem. 60:1996;23-32.
160. Grilli M., Pizzi M., Memo M., Spano P.G. Neuroprotection by aspirin and sodium salicylate through blockade of NF-κB activation. Science. 274:1996;1383-1385.
161. Grimm S., Bauer M.K., Baeuerle P.A., Schulze-Osthoff K. Bcl-2 down-regulates the activity of transcription factor NF-κB induced upon apoptosis. J. Cell. Biol. 134:1996;13-23.
162. Ivanov V.N., Lee R.K., Rodack E.R., Malek T.R. Regulation of Fas-dependent activation-induced T cell apoptosis by cAMP signaling: a potential role for transcription factor NF-κB. Oncogene. 14:1997;2455-2464.
163. Kasibhata S., Brunner T., Genestier L., Echeverri F., Hahboubi A., Green A.R. DNA damaging agents induce expression of Fas ligand and subsequent apoptosis in T lymphocytes via the activation of NF-κB and AP-1. Mol. Cell. 1:1998;543-551.
164. Chan H., Bartos D.P., Owen-Schaub L.B. Activation dependent transcriptional regulation of the human Fas promoter requires NF-κB p50-p65 recruitment. Mol. Cell. Biol. 19:1999;2098-2108.
165. Hettmann T., Didonato J., Karin M., Leiden J.M. An essential role for NF-κB in promoting double positive thymocyte apoptosis. J. Exp. Med. 189:1999;145-157.
166. Inohara N., Koseki T., del Peso L., Hu Y., Yee C., Chen S., Carrio R., Merino J., Liu D., Ni J., Nunez G. Nod1, an Apaf-1-like activator of caspase-9 and NF-κB. J. Biol. Chem. 274:1999;14,560-14,567.
167. Bertin J., Nir W.J., Fischer C.M., Tayber O.V., Errada P.R., Grant J.R., Keilty J.J., Gosselin M.L., Robison K.E., Wong G.H., Glucksman M.A., DiStefano P.S. Human CARD4 protein is a novel CED-4/Apaf-1 cell death family member that activates NF-κB. J. Biol. Chem. 274:1999;12,955-12,958.
168. Herbein G., van Lint C., Lovett J.L., Verdin E. Distinct mechanisms trigger apoptosis in human immunodeficiency virus type 1-infected and in uninfected bystander T lymphocytes. J. Virol. 72:1998;660-670.
169. + T cells during an immune response to HIV-1-pulsed dendritic cells. AIDS Res. Hum. Retrovir. 10:1994;61-71.
170. + T cells in vitro: differential induction of apoptosis in these cells. J. Immunol. 152:1994;330-342.
171. Meyaard L., Otto S.A., Jonker R.R., Mijnster M.J., Keet R.P., Miedema F. Programmed death of T cells in HIV-1 infection. Science. 257:1992;217-219.
172. Ho D.D., Neumann A.U., Perelson A.S., Chen W., Leonard J.M., Markowitz M. Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection. Nature. 373:1995;123-126.
173. Wei X., Ghosh S.K., Taylor M.E., Johnson V.A., Emini E., Deutsch P., Lifson J.D., Bonhoeffer S., Nowak M.A., Hahn B.H., Saag M.S., Shaw G.M. Viral dynamics in human immunodeficiency virus type 1 infection. Nature. 373:1995;117-122.
174. + T cell depletion in mice doubly transgenic for HIV gp120 and human CD4. Eur. J. Immunol. 27:1997;1319-1324.
175. Chirmule N., Pahwa S. Envelope glycoproteins of human immunodeficiency virus type 1: profound influences on immune functions. Microbio. Rev. 60:1996;386-406.
176. Siciliano R.F. The role of CD4 in HIV envelope-mediated pathogenesis. Curr. Topics Micro. Immuno. 205:1996;159-179.
177. Choy E.H., Adjaye J., Forrest L., Kingsley G.H., Panayi G.S. Chimeric anti-CD4 monoclonal antibody cross-linked by monocyte Fc gamma receptor mediates apoptosis of human CD4 lymphocytes. Eur. J. Immunol. 23:1993;2676-2681.
178. Oyaizu N., McCloskey T.W., Than S., Hu R., Kalyanaraman V.S., Pahwa S. Crosslinking of CD4 molecules upregulates Fas antigen expression in lymphocytes by inducing interferon-γ and tumor necrosis-α secretion. Blood. 94:1994;2622-2631.
179. Hashimoto F., Oyaizu N., Kalyanaraman V.S., Pahwa S. Modulation of Bcl-2 protein by CD4 cross-linking: a possible mechanism for lymphocyte apoptosis in human immunodeficiency virus infection and for rescue of apoptosis by interleukin-2. Blood. 90:1997;745-753.
180. Rosenberg Y.J., Anderson A.O., Pabst R. HIV-induced decline in blood CD4/CD8 ratios: viral killing or altered lymphocyte trafficking? Immunol. Today. 19:1998;10-17.
181. Westermann J., Persin S., Matyas J., van der Meide P., Pabst R. IFN-γ influences the migration of thoracic duct B and T lymphocyte subsets in vivo: random increase in disappearance from the blood and differential decrease in reappearance in the lymph. J. Immunol. 150:1993;3843-3852.
182. Finkel T.H., Tudor-Williams G., Banda N.K., Cotton M.F., Curiel T., Monks C., Baba T.W., Ruprecht R.M., Kupfer A. Apoptosis occurs predominantly in bystander cells and not in productively infected cells of HIV- and SIV-infected lymph nodes. Nature Med. 1:1995;129-138.
183. Badley A.D., McElhinny J.A., Leibson P.J., Lynch D.H., Alderson M.R., Paya C.V. Upregulation of Fas ligand expression by human immunodeficiency virus in human macrophages mediates apoptosis of uninfected T lymphocytes. J. Virol. 70:1996;199-206.
184. + T lymphocytes from HIV-infected individuals is mediated by Fas-L and tumor necrosis factor. J. Exp. Med. 185:1997;55-64.
185. Li C.J., Friedman D.J., Wang C., Metelev V., Pardee A.B. Induction of apoptosis in unifected lymphocytes by HIV-1 Tat protein. Science. 268:1995;429-431.
186. Westendorp M.O., Frank R., Ochsenbauer C., Stricker K., Dhein J., Walczak H., Debatin K.-M., Krammer P.H. Sensitization of T cells to CD95-mediated apoptosis by HIV-1 Tat and gp120. Nature. 375:1995;497-500.
187. Green D.R., Reed J.C. Mitochondria and apoptosis. Science. 281:1998;1309-1312.
188. Orenstein J.M., Fox C., Wahl S.M. Macrophages as a source of HIV during opportunistic infections. Science. 276:1997;1857-1860.
189. + T cell in human-PBL-SCID mice infected by noncytopathic HIV isolates. Science. 260:1993;689-692.
190. Zheng L., Fisher G., Miller E., Peschon J., Lynch D.H., Lenardo M.J. Induction of apoptosis in mature T cells by tumour necrosis factor. Nature. 377:1995;348-351.
191. Weller S.K., Temin H.M. Cell killing by avian leukosis viruses. J. Virol. 39:1981;713-721.
192. Ozes O.S., Mayo L., Gustin J.A., Pfeffer S.R., Pfeffer L.M., Donner D.B. NF-κB activation by tumour necrosis factor requires the Akt serine-threonine kinase. Nature. 401:1999;82-85.
193. Romashkova J.A., Makarov S.S. NF-κB is a target of AKT in anti-apoptotic PDGF signalling. Nature. 401:1999;86-89.